keyword
https://read.qxmd.com/read/38615313/the-temporal-association-between-adverse-drug-reactions-and-antirheumatic-drugs-utilisation-in-western-australia-a-retrospective-study-from-real-world-data-1995-2015
#1
JOURNAL ARTICLE
Khalid B Almutairi, Charles A Inderjeeth, David B Preen, Helen I Keen, Johannes C Nossent
BACKGROUND/OBJECTIVES: Adverse drug reactions (ADRs) can result in morbidity, mortality, and higher healthcare costs. Given the limited information available on ADRs associated with antirheumatic medications, this study aims to analyse and compare ADR reporting for these drugs in the pharmacovigilance datasets of Western Australia (WA) and the United States (US). METHODS: Therapeutic Goods Administration provided WA pharmacovigilance data of selected antirheumatic drugs to from 1995 to 2015...
April 14, 2024: Rheumatology International
https://read.qxmd.com/read/38615143/post-transplant-cyclophosphamide-calcineurin-inhibitor-and-mycophenolate-mofetil-compared-to-anti-thymocyte-globulin-calcineurin-inhibitor-and-methotrexate-combinations-as-graft-versus-host-disease-prophylaxis-post-allogeneic-stem-cell-transplantation-from
#2
JOURNAL ARTICLE
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Kulagin, Jakob Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spyridonidis, Eolia Brissot, Fabio Ciceri, Mohamad Mohty
Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus or cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte globulin plus CNI (tacrolimus or cyclosporine A) plus methotrexate (ATG/TAC or CSA/MTX) are common graft-versus-host disease (GVHD) prophylaxis regimens. We compared the two regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic transplantation from matched siblings or unrelated donors. 402 received PTCy/TAC or CSA/MMF and 5648 received ATG/TAC or CSA/MTX...
April 13, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38613330/retrospective-review-of-the-toxicities-and-change-in-dosing-patterns-for-pegaspargase-in-patients-with-acute-lymphoblastic-leukemia-lymphoma-and-t-cell-lymphoma
#3
JOURNAL ARTICLE
Grace Baek, Miryoung Kim, Madison Lee, Shan O'Connor, Lauren Held, Lars van der Laan, Ryan D Cassaday
INTRODUCTION: Pegaspargase (PEG) is a key component of standard regimens for acute lymphoblastic leukemia/lymphoma (ALL) and extranodal natural killer/T-cell lymphoma (NKTCL). Emerging evidence suggests an opportunity to decrease incidence of PEG-associated toxicities with dose capping, but evidence is limited. This study aims to evaluate whether a significant difference in PEG-associated toxicities related to dosing strategy exists and to identify patient-specific or regimen-specific factors for PEG-related toxicity...
April 13, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38612988/preventative-effects-of-milk-fat-globule-membrane-ingredients-on-dss-induced-mucosal-injury-in-intestinal-epithelial-cells
#4
JOURNAL ARTICLE
Erica Kosmerl, Celeste Miller, Rafael Jiménez-Flores
The goblet cells of the gastrointestinal tract (GIT) produce glycoproteins called mucins that form a protective barrier from digestive contents and external stimuli. Recent evidence suggests that the milk fat globule membrane (MFGM) and its milk phospholipid component (MPL) can benefit the GIT through improving barrier function. Our objective was to compare the effects of two digested MFGM ingredients with or without dextran sodium sulfate (DSS)-induced barrier stress on mucin proteins. Co-cultured Caco-2/HT29-MTX intestinal cells were treated with in vitro digests of 2%, 5%, and 10% ( w / v ) MFGM or MPL alone for 6 h or followed by challenge with 2...
March 26, 2024: Nutrients
https://read.qxmd.com/read/38612819/therapeutic-advances-and-challenges-for-the-management-of-hpv-associated-oropharyngeal-cancer
#5
REVIEW
Isis de Araújo Ferreira Muniz, Megan Araujo, Jenna Bouassaly, Fatemeh Farshadi, Mai Atique, Khashayar Esfahani, Paulo Rogerio Ferreti Bonan, Michael Hier, Marco Mascarella, Alex Mlynarek, Moulay Alaoui-Jamali, Sabrina Daniela da Silva
The use of conventional chemotherapy in conjunction with targeted and immunotherapy drugs has emerged as an option to limit the severity of side effects in patients diagnosed with head and neck cancer (HNC), particularly oropharyngeal cancer (OPC). OPC prevalence has increased exponentially in the past 30 years due to the prevalence of human papillomavirus (HPV) infection. This study reports a comprehensive review of clinical trials registered in public databases and reported in the literature (PubMed/Medline, Scopus, and ISI web of science databases)...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611843/redox-responsive-gold-nanoparticles-coated-with-hyaluronic-acid-and-folic-acid-for-application-in-targeting-anticancer-therapy
#6
JOURNAL ARTICLE
Raissa Munderere, Muhammad Gulfam, Israr Ali, Seon-Hwa Kim, Trung Thang Vu, Sang-Hyug Park, Kwon Taek Lim
Methotrexate (MTX) has poor water solubility and low bioavailability, and cancer cells can become resistant to it, which limits its safe delivery to tumor sites and reduces its clinical efficacy. Herein, we developed novel redox-responsive hybrid nanoparticles (NPs) from hyaluronic acid (HA) and 3-mercaptopropionic acid (MPA)-coated gold NPs (gold@MPA NPs), which were further conjugated with folic acid (FA). The design of FA-HA-ss-gold NPs aimed at enhancing cellular uptake specifically in cancer cells using an active FA/HA dual targeting strategy for enhanced tumor eradication...
March 31, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38610976/copy-number-analysis-of-9p24-1-in-classic-hodgkin-lymphoma-arising-in-immune-deficiency-dysregulation
#7
JOURNAL ARTICLE
Kumiko Ohsawa, Shuji Momose, Asami Nishikori, Midori Filiz Nishimura, Yuka Gion, Keisuke Sawada, Morihiro Higashi, Michihide Tokuhira, Jun-Ichi Tamaru, Yasuharu Sato
A subset of patients with rheumatoid arthritis receiving methotrexate develop immune deficiencies and dysregulation-associated lymphoproliferative disorders. Patients with these disorders often exhibit spontaneous regression after MTX withdrawal; however, chemotherapeutic intervention is frequently required in patients with classic Hodgkin lymphoma arising in immune deficiency/dysregulation. In this study, we examined PD-L1 expression levels and 9p24.1 copy number alterations in 27 patients with classic Hodgkin lymphoma arising from immune deficiency/dysregulation...
March 27, 2024: Cancers
https://read.qxmd.com/read/38610627/risk-factors-associated-with-adverse-events-leading-to-methotrexate-withdrawal-in-elderly-rheumatoid-arthritis-patients-a-retrospective-cohort-study
#8
JOURNAL ARTICLE
Felipe Alexis Avalos-Salgado, Laura Gonzalez-Lopez, Sergio Gonzalez-Vazquez, Juan Manuel Ponce-Guarneros, Aline Priscilla Santiago-Garcia, Edna Lizeth Amaya-Cabrera, Reynaldo Arellano-Cervantes, J Ahuixotl Gutiérrez-Aceves, Miriam Fabiola Alcaraz-Lopez, Cesar Arturo Nava-Valdivia, Fabiola Gonzalez-Ponce, Norma Alejandra Rodriguez-Jimenez, Miguel Angel Macias-Islas, Edgar Ricardo Valdivia-Tangarife, Ana Miriam Saldaña-Cruz, Ernesto German Cardona-Muñoz, Jorge Ivan Gamez-Nava
Background: Rheumatoid arthritis (RA) in elderly population represents a challenge for physicians in terms of therapeutic management. Methotrexate (MTX) is the first-line treatment among conventional synthetic-disease-modifying anti-rheumatic drugs (cs-DMARDs); however, it is often associated with adverse events (AEs). Therefore, the objective of this study was to identify the incidence and risk factors of MTX discontinuation due to AEs in elderly patients with RA in a long-term retrospective cohort study. Methods: Clinical sheets from elderly RA patients taking MTX from an outpatient rheumatology consult in a university centre were reviewed...
March 24, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609109/update-on-the-use-of-methotrexate-in-the-management-of-rheumatoid-arthritis
#9
JOURNAL ARTICLE
R Matloob, Z Althanoon, S Algburi, M Salih, M Merkhan
Rheumatoid arthritis (RA) is an auto-immune disorder described by permanent inflammation of the articular synovial membrane. Non-treated RA can cause gradual joint damage, ending in complaint, poor lifestyle, and an upright ratio of death. Approximately one percent of the people are involved, and the disorder begins, in general, appears during the third and fifth decades of age, with more occurrences in females. The treatment is complicated as well as involves various stages of medications with variable methods of application as well as non-pharmacologic methods...
February 2024: Georgian Medical News
https://read.qxmd.com/read/38609057/combinational-strategy-using-albumin-based-nanoparticles-to-enable-synergetic-anti-rheumatic-efficacy-and-reduced-hepatotoxicity
#10
JOURNAL ARTICLE
Jiao Li, Xiqian Zhang, Lihua Pan, Xin Lin, Bin Zhang, Jianheng Ren, Qin Wang
Methotrexate (MTX) is recognized as the golden standard for rheumatoid arthritis (RA) treatment. However, it can cause liver damage in long-term application. Although nanomedicines can target to inflamed sites, most of them tend to accumulate in liver. Glycyrrhizinic acid (GA) holds potential to reverse MTX-associated hepatotoxicity. The combination of GA and MTX might achieve a synergistic anti-inflammatory efficacy and reduced hepatotoxicity. As MTX and GA have totally different in vivo performance, it is necessary to co-encapsulate them in one carrier to coordinate their in vivo fates...
April 10, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38607071/a-novel-approach-for-glioblastoma-treatment-by-combining-apoptosis-inducers-tmz-mtx-and-cytarabine-with-e-v-a-eltanexor-venetoclax-and-a1210477-inhibiting-xpo1-bcl-2-and-mcl-1
#11
JOURNAL ARTICLE
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, R Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg W Bartsch, Tillmann Rusch
Adjuvant treatment for Glioblastoma Grade 4 with Temozolomide (TMZ) inevitably fails due to therapeutic resistance, necessitating new approaches. Apoptosis induction in GB cells is inefficient, due to an excess of anti-apoptotic XPO1/Bcl-2-family proteins. We assessed TMZ, Methotrexate (MTX), and Cytarabine (Ara-C) (apoptosis inducers) combined with XPO1/Bcl-2/Mcl-1-inhibitors (apoptosis rescue) in GB cell lines and primary GB stem-like cells (GSCs). Using CellTiter-Glo® and Caspase-3 activity assays, we generated dose-response curves and analyzed the gene and protein regulation of anti-apoptotic proteins via PCR and Western blots...
April 4, 2024: Cells
https://read.qxmd.com/read/38605933/from-intramural-ectopic-pregnancy-to-hysterectomy-a-case-report
#12
Rhys Harris, Wasim Awal, Sebastian Jacob-Rogers, Graeme Walker
An intramural ectopic pregnancy is one of the rarest types of ectopic pregnancy, and due to the scarcity of reported cases there are no clear guidelines regarding diagnosis and management of the condition. We report a case of a non-viable intramural ectopic pregnancy managed with intravenous methotrexate, in a patient with no previous pregnancies but a history of uterine cornual cyst excision. The patient subsequently developed a uterine arteriovenous malformation, which was embolised. Following this, she had two pregnancies, one culminating in an elective caesarean section at term, and the other a medical termination of pregnancy at 19 weeks of gestation...
March 2024: Case Reports in Women's Health
https://read.qxmd.com/read/38605857/tobacco-smoking-negatively-influences-the-achievement-of-greater-than-three-quarters-reduction-in-psoriasis-area-and-severity-index-after-eight-weeks-of-treatment-among-patients-with-psoriasis-findings-from-a-prospective-study
#13
JOURNAL ARTICLE
Yan Qiang, Le Kuai, Shuo Liu, Quanruo Xu, Lingzi Shenfan, Rui Zhang, Zhongzhi Gao, Xiangjin Gao, Bin Li, Ruiping Wang
INTRODUCTION: Smoking is an independent and modifiable risk factor for the onset and development of psoriasis; however, evidence on the association between tobacco smoking and psoriasis treatment efficacy is limited. This study aimed to explore the influence of smoking on treatment efficacy in a cohort of patients with psoriasis in Shanghai, China. METHODS: Patients with psoriasis were recruited from the Shanghai Skin Disease Hospital between 2021 and 2022. The treatment for patients with psoriasis includes acitretin, methotrexate, narrow-band ultraviolet/benvitimod, and biologics...
2024: Tobacco Induced Diseases
https://read.qxmd.com/read/38604797/-clinical-study-of-15-cases-of-primary-non-immunodeficient-central-nervous-system-lymphoma-in-children
#14
JOURNAL ARTICLE
H X Gao, N N Zhang, C J Zhou, L Jin, J Yang, S Huang, M Zhang, N Li, Y H Zhang, Y L Duan
Clinical data of 15 primary central nervous system lymphoma (PCNSL) children aged ≤18 years admitted to our hospital between May 2013 to May 2023 were retrospectively analyzed. Our goal was to summarize the clinical features of children and investigate the therapeutic effect of a high-dose methotrexate (HD-MTX) based chemotherapy regimen on this disease. The male-to-female ratio was 2.7∶1, and the median age was 7.2 (2.3-16.4) years at diagnosis. The initial clinical symptoms were primarily cranial hypertension, with imaging findings revealing multiple lesions...
February 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38604788/-clinical-study-of-the-efficacies-of-ruxolitinib-plus-low-dose-ptcy-for-acute-gvhd-prevention-after-haploidentical-transplantation-in-malignant-hematological-diseases
#15
JOURNAL ARTICLE
X P Li, Y Li, L Liu, Z T Yuan, Y C Wang, Y C Dong, D S Zhang, J Feng, Y N Chen, S B Wang
Objective: To investigate and verify a novel acute graft versus host disease (aGVHD) prevention protocol in the context of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) . Methods: Patients who underwent haplo-HSCT in our center between January 2022 and December 2022 were included. All patients received reduced doses of cyclophosphamide, Rabbit anti-human tymoglobulin, ruxolitinib, methotrexate, cyclosporine, and MMF to prevent aGVHD. The transplantation outcomes, complications, and survival rate of all patients were investigated...
February 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38603864/direct-radiolabeling-of-methotrexate-and-methotrexate-micelles-with-tc-99m-using-qbd-approach
#16
JOURNAL ARTICLE
Prashant G Upadhaya, Swapna J Nabar
The aim of the work presented in this manuscript was to radiolabel methotrexate and prepare radiolabeled methotrexate micelles, an antifolate drug with Tc-99m using QbD approach. The radiolabeling was executed using the experimental design and the radiolabeled drug was further encapsulated in micelles. The authors are of the view that the radiolabeled MTX could be used to target the folate receptor overexpressing cancers such as the kidney, colorectal, breast, brain etc thereby opening newer possibilities to the theranostic applications of the formed conjugate...
April 7, 2024: Applied Radiation and Isotopes
https://read.qxmd.com/read/38602169/haploidentical-hematopoietic-stem-cell-transplantation-with-busulfan-cyclophosphamide-and-fludarabine-conditioning-for-x-linked-adrenal-cerebral-leukodystrophy
#17
JOURNAL ARTICLE
Yao Chen, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Kai-Yan Liu, Jiong Qing, Yan-Ling Yang, Xiao-Jun Huang
OBJECTIVE: We investigated the safety and efficacy of haploidentical stem cell transplantation (SCT) in pediatric patients with X-linked adrenoleukodystrophy (ALD). METHODS: A retrospective analysis of transplantation data from 29 cases of ALD, treated between December 2014 and April 2022, was conducted. Neurologic function scores (NFS) were assessed. The conditioning regimen was busulfan 9.6 mg/kg, cyclophosphamide 200 mg/kg, and fludarabine 90 mg/m2 (BFC)...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38601347/microenvironmental-enzyme-responsive-methotrexate-modified-quercetin-micelles-for-the-treatment-of-rheumatoid-arthritis
#18
JOURNAL ARTICLE
Xiuying Li, Xin Wang, Xiuwu Qu, Ningning Shi, Qinqing Li, Zhifang Yan, Yandong Li, Yingli Wang
PURPOSE: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease involving synovial inflammation and joint destruction. Although therapeutic drugs for RA have some efficacy, they usually cause severe side effects and are expensive. RA is characterized by synovial hyperplasia, intra-articular hypoxia, upregulated expression of matrix metalloproteinases, and excessive accumulation of reactive oxygen species. The adverse microenvironment further aggravates activated macrophage infiltration...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38601162/bioinformatics-and-system-biology-approach-to-identify-the-influences-among-covid-19-influenza-and-hiv-on-the-regulation-of-gene-expression
#19
JOURNAL ARTICLE
Zhen Zhang, Hao Jin, Xu Zhang, Mei Bai, Kexin Zheng, Jing Tian, Bin Deng, Lingling Mao, Pengcheng Qiu, Bo Huang
BACKGROUND: Coronavirus disease (COVID-19), caused by SARS-CoV-2, has emerged as a infectious disease, coexisting with widespread seasonal and sporadic influenza epidemics globally. Individuals living with HIV, characterized by compromised immune systems, face an elevated risk of severe outcomes and increased mortality when affected by COVID-19. Despite this connection, the molecular intricacies linking COVID-19, influenza, and HIV remain unclear. Our research endeavors to elucidate the shared pathways and molecular markers in individuals with HIV concurrently infected with COVID-19 and influenza...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38600056/network-based-identification-of-key-proteins-and-repositioning-of-drugs-for-non-small-cell-lung-cancer
#20
JOURNAL ARTICLE
Oluwatosin Maryam Adeyemo, Zainab Ashimiyu-Abdusalam, Mary Adewunmi, Temitope Ayanfunke Ayano, Muhammad Sohaib, Reem Abdel-Salam
BACKGROUND: NSCLC is a lethal cancer that is highly prevalent and accounts for 85% of cases of lung cancer. Conventional cancer treatments, such as chemotherapy and radiation, frequently exhibit limited efficacy and notable adverse reactions. Therefore, a drug repurposing method is proposed for effective NSCLC treatment. AIMS: This study aims to evaluate candidate drugs that are effective for NSCLC at the clinical level using a systems biology and network analysis approach...
April 2024: Cancer reports
keyword
keyword
81994
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.